Mark Simon

Mr. Simon joined Cabaletta’s Board of Directors in October 2018. He is a partner and co-founder of, and advisor to, Torreya Partners, LLC, a global investment banking firm serving companies in the life sciences industry. Prior to co-founding Torreya, Mr. Simon was a managing director and head of life sciences investment banking at Citigroup from 2002 to 2005, and a senior biotechnology research analyst at Robertson Stephens from 1989 to 2002. He began his career at Kidder Peabody. Mr. Simon is a strategic advisor to Sun Pharma Advanced Research Company Limited, a public company in India. Mr. Simon formerly served on the boards of directors of ControlRad Systems from 2012 to 2019 and Hutchinson Water International Holdings Limited from 2014 to 2018. Mr. Simon also serves on the board of several disease advocacy and philanthropic foundations. He received his M.B.A. from Harvard Business School and his B.A. from Columbia College.